After much bureaucratic silliness, a generic pharmaceutical company can now begin production of a drug that helps people suffering from HIV/AIDs. Rwanda had to notify of their intention of importing the drug then get approval for the drug to even be manufactured (that’s the simple version). The point is that soon in Rwanda people will be better treated.
Rwanda plans to import 260,000 packs of TriAvir from Canada. The drug is a fixed-dose combination of widely used anti-AIDS drugs lamivudine, zidovudine and nevirapine. The generic product is manufactured in Canada by Apotex Inc.